Lee's Pharmaceutical Holdings Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 10.2yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem
Sep 04
There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price
Aug 07Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01
May 21Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking
Dec 20Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
May 21Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Apr 02Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Aug 29Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?
Apr 05Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?
Mar 17Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?
Feb 22What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 29CEO
Lee's Pharmaceutical Holdings has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Compliance Officer | no data | HK$12.18m | 0.14% HK$ 1.1m | |
| Founder | 3.7yrs | HK$6.54m | 9.99% HK$ 81.8m | |
| MD, Chief Marketing & Sales Officer and Executive Director | 21.3yrs | HK$13.20m | 1.43% HK$ 11.7m | |
| Group CFO & Company Secretary | 10.2yrs | no data | no data | |
| Director of Administration in China | no data | no data | no data | |
| Group Chief Manufacturing Officer | 12.9yrs | no data | no data | |
| Chief Medical Officer | 3.3yrs | no data | no data | |
| Group Deputy GM & GM of the Risk Control Centre | no data | no data | no data |
10.2yrs
Average Tenure
61yo
Average Age
Experienced Management: 950's management team is seasoned and experienced (10.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Compliance Officer | no data | HK$12.18m | 0.14% HK$ 1.1m | |
| Founder | no data | HK$6.54m | 9.99% HK$ 81.8m | |
| MD, Chief Marketing & Sales Officer and Executive Director | no data | HK$13.20m | 1.43% HK$ 11.7m | |
| Non-Executive Director | less than a year | no data | 0.085% HK$ 695.0k | |
| Non-Executive Director | 2.9yrs | HK$300.00k | no data | |
| Independent Non-Executive Director | 22.9yrs | HK$216.00k | 0.088% HK$ 722.8k | |
| Independent Non-Executive Director | 20.3yrs | HK$216.00k | 0.051% HK$ 417.0k | |
| Independent Non Executive Director | 1.6yrs | HK$135.00k | no data |
2.9yrs
Average Tenure
63yo
Average Age
Experienced Board: 950's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:38 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lee's Pharmaceutical Holdings Limited is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Cheng | 3V Capital Limited |
| Yue-Kwong Lui | BOCOM International Securities Limited |
| Chu Wang | Citigroup Inc |